Risks and Benefits of Antiplatelet Therapy in Uremic Patients

被引：12
作者：
Washam, Jeffrey B.
Adams, George L. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Duke Heart Ctr, Durham, NC 27710 USA
来源：
ADVANCES IN CHRONIC KIDNEY DISEASE | 2008年 / 15卷 / 04期
关键词：
Uremia; Antiplatelet therapy; Acute coronary syndrome;
D O I：
10.1053/j.ackd.2008.07.006
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with renal insufficiency are at an increased risk for cardiovascular morbidity and mortality. Despite being at a substantial risk for thrombotic events, patients with renal insufficiency also experience a greater number of hemorrhagic complications associated with antiplatelet therapy than individuals with normal renal function. This review focuses on the benefits and risks of antiplatelet therapy in patients with impaired kidney function suffering from an acute coronary syndrome. (C) 2008 by the National Kidney Foundation, Inc. All rights reserved
引用
收藏
页码：370 / 377
页数：8
相关论文
共 50 条
  • [41] Pharmacogenomic Testing to Select Antiplatelet Therapy
    Price, Matthew J.
    Angiolillo, Dominick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (17) : 1878 - 1881
  • [42] Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction The Twilight of Prolonged DAPT Duration?
    Lev, Eli I.
    Ben-Assa, Eyal
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (03) : 294 - 296
  • [43] Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage
    Baschin, M.
    Selleng, S.
    Zeden, J. -P.
    Westphal, A.
    Kohlmann, T.
    Schroeder, H. W.
    Greinacher, A.
    Thiele, T.
    VOX SANGUINIS, 2017, 112 (06) : 535 - 541
  • [44] Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls
    Winter, Max-Paul
    Kozinski, Marek
    Kubica, Jacek
    Aradi, Daniel
    Siller-Matula, Jolanta M.
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2015, 11 (04): : 259 - 280
  • [45] Clinical benefits and risks of antithrombotic therapy in patients with atrial fibrillation with comorbidities - A report fromthe CHART-2 Study
    Shiroto, Takashi
    Sakata, Yasuhiko
    Nochioka, Kotaro
    Abe, Ruri
    Kasahara, Shintaro
    Sato, Masayuki
    Aoyanagi, Hajime
    Fujihashi, Takahide
    Yamanaka, Shinsuke
    Hayashi, Hideka
    Miura, Masanobu
    Takahashi, Jun
    Miyata, Satoshi
    Shimokawa, Hiroaki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 299 : 160 - 168
  • [46] Tailoring antiplatelet therapy in older patients with coronary artery disease
    Kovacevic, Mila
    Pompei, Graziella
    Kunadian, Vijay
    PLATELETS, 2023, 34 (01)
  • [47] Antiplatelet therapy for patients undergoing coronary artery bypass surgery
    DeStephan, Christine M.
    Schneider, David J.
    KARDIOLOGIA POLSKA, 2018, 76 (06) : 945 - 952
  • [48] Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk
    Smits, Pieter C.
    Frigoli, Enrico
    Vranckx, Pascal
    Ozaki, Yukio
    Morice, Marie -Claude
    Chevalier, Bernard
    Onuma, Yoshinobu
    Windecker, Stephan
    Tonino, Pim A. L.
    Roffi, Marco
    Lesiak, Maciej
    Mahfoud, Felix
    Bartunek, Jozef
    Hildick-Smith, David
    Colombo, Antonio
    Stankovic, Goran
    Iniguez, Andres
    Schultz, Carl
    Kornowski, Ran
    Ong, Paul J. L.
    Alasnag, Mirvat
    Rodriguez, Alfredo E.
    Paradies, Valeria
    Kala, Petr
    Kedev, Sasko
    Al Mafragi, Amar
    Dewilde, Willem
    Heg, Dik
    Valgimigli, Marco
    MASTER DAPT Investigators
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (13) : 1220 - 1237
  • [49] Antiplatelet therapy in patients with claudication: lessons from large trials
    Dormandy, JA
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2002, 4 (0B) : B55 - B57
  • [50] Endoscopic sinus surgery in patients receiving anticoagulant or antiplatelet therapy
    Sargi, Zoukaa
    Casiano, Roy
    AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (03): : 335 - 338
12345